![Rémy Henri Luthringer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rémy Henri Luthringer
Directeur Général chez
MINERVA NEUROSCIENCES, INC.
Fortune : 907 461 $ au 31/05/2026
Profil
Rémy Henri Luthringer is the founder of Somno-Art.
Dr. Luthringer is Executive Chairman & Chief Executive Officer at Minerva Neurosciences, Inc. since 2017 and has been with the company since 2010.
Dr. Luthringer is Director at Centessa Pharmaceuticals (Orexia) Ltd. since 2019.
Former roles include Chief Executive Officer at FORENAP Pharma SARL from 2009 to 2014, Director at Mind-NRG SARL, Director at Inexia Ltd., Venture Partner at Index Ventures SA from 2010 to 2019, and Chief Medical Officer at Index Venture Management (US), Inc. Education includes graduate studies at Université Pierre et Marie Curie and a doctorate from the University of Strasbourg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/06/2026 | 184 819 ( 0,4% ) | 907 461 $ | 31/05/2026 |
Postes actifs de Rémy Henri Luthringer
| Sociétés | Poste | Début |
|---|---|---|
| MINERVA NEUROSCIENCES, INC. | Directeur Général | 01/11/2014 |
Orexia Therapeutics Ltd.
 Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops orally orexin positive modulators for the treatment of neurological diseases | Directeur/Membre du Conseil | 16/04/2019 |
Anciens postes connus de Rémy Henri Luthringer
| Sociétés | Poste | Fin |
|---|---|---|
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures invests companies across the globe. The firm target companies operating across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | 31/12/2019 |
FORENAP Pharma SARL
 FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research | Directeur Général | 25/03/2014 |
Inexia Ltd.
 Inexia Ltd. Medical SpecialtiesHealth Technology Develops intranasal positive modulators | Directeur/Membre du Conseil | - |
Index Venture Management (US), Inc.
 Index Venture Management (US), Inc. Investment ManagersFinance Index Venture Management focuses on seed, early-stage and growth investments in information technology and life sciences companies. The firm seeks to invest in companies that focus on markets that are already very large and profitable or that are expected to experience explosive growth. They target companies with the potential to be market leaders in well-identified market segments with annual sales greater than $1 billion. | Directeur Technique/Scientifique/R&D | - |
Somno-Art
 Somno-Art Medical SpecialtiesHealth Technology Manufactures ambulatory medical devices | Fondateur | - |
Formation de Rémy Henri Luthringer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Index Ventures SA
Index Ventures SA Investment ManagersFinance Index Ventures invests companies across the globe. The firm target companies operating across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strasbourg
 University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research | Commercial Services |
Mind-NRG SARL
 Mind-NRG SARL Medical/Nursing ServicesHealth Services Provides research and drug development services | Health Services |
Index Venture Management (US), Inc.
Index Venture Management (US), Inc. Investment ManagersFinance Index Venture Management focuses on seed, early-stage and growth investments in information technology and life sciences companies. The firm seeks to invest in companies that focus on markets that are already very large and profitable or that are expected to experience explosive growth. They target companies with the potential to be market leaders in well-identified market segments with annual sales greater than $1 billion. | Finance |
Minerva Neurosciences, Inc.
 Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Somno-Art
Somno-Art Medical SpecialtiesHealth Technology Manufactures ambulatory medical devices | Health Technology |
Inexia Ltd.
Inexia Ltd. Medical SpecialtiesHealth Technology Develops intranasal positive modulators | Health Technology |
Orexia Therapeutics Ltd.
Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops orally orexin positive modulators for the treatment of neurological diseases | Commercial Services |
Choisissez Zonebourse 
